These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 12219606)
1. [After discontinuation of the Women's Health Initiative Study of hormone substitution. Should hormone replacement be stopped? (interview by Dr. Brigitte Moreano)]. Seifert-Klauss V MMW Fortschr Med; 2002 Jul; 144(29-30):16. PubMed ID: 12219606 [No Abstract] [Full Text] [Related]
2. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy]. Stjernquist M; Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859 [TBL] [Abstract][Full Text] [Related]
3. [Current debate on hormone replacement therapy]. Georges B; Hermelink K; Untch M; Hepp H Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):63-8. PubMed ID: 15073435 [TBL] [Abstract][Full Text] [Related]
4. [Hormone replacement therapy: curse or blessing?]. Schmidt M; Fink D; Lang U; Kimmig R Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400 [TBL] [Abstract][Full Text] [Related]
5. [What do you prescribe for climacteric symptoms? (interview by Friederike Klein)]. Ortmann O MMW Fortschr Med; 2005 Nov; 147(47):21. PubMed ID: 16370190 [No Abstract] [Full Text] [Related]
6. [Hormone replacement therapy and the risk of developing breast cancer]. Merz WE MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702 [TBL] [Abstract][Full Text] [Related]
7. A personal initiative for women's health: to challenge the Women's Health Initiative. Genazzani AR; Gambacciani M Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552 [No Abstract] [Full Text] [Related]
8. A comparative review of the risks and benefits of hormone replacement therapy regimens. Warren MP Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656 [TBL] [Abstract][Full Text] [Related]
9. Health risks after cessation of postmenopausal hormone therapy. Pines A; Sturdee D; Birkhäuser M; Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782 [No Abstract] [Full Text] [Related]
11. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy. Haskell SG J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661 [TBL] [Abstract][Full Text] [Related]
12. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer]. Magnusson C; Weiderpass E Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082 [TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences? Mikkola TS; Clarkson TB; Notelovitz M Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292 [TBL] [Abstract][Full Text] [Related]
14. [Benefits and risks of postmenopausal hormone replacement therapy. Symptoms improved but not a better outcome?]. MMW Fortschr Med; 2010 Jun; 152(24):18. PubMed ID: 20672580 [No Abstract] [Full Text] [Related]
15. Where are we with postmenopausal hormone therapy in 2005? Lam PM; Chung TK; Haines C Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243 [TBL] [Abstract][Full Text] [Related]
16. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s]. Magnusson C; Reeves G Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095 [No Abstract] [Full Text] [Related]
17. [New insights on the effects of hormone replacement therapy on the breast tissue and the orgnaism]. Kubista E Wien Klin Wochenschr; 2003; 115 Suppl 2():46-9. PubMed ID: 15518146 [TBL] [Abstract][Full Text] [Related]
18. Menopausal hormone therapy: currently no evidence for cardiac protection. Wenger NK Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336 [TBL] [Abstract][Full Text] [Related]